Bone Morphogenetic Protein Receptors, Type I
"Bone Morphogenetic Protein Receptors, Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of bone morphogenetic protein receptors with high affinity for BONE MORPHOGENETIC PROTEINS. They can interact with and undergo PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II. They signal primarily through RECEPTOR-REGULATED SMAD PROTEINS.
Descriptor ID |
D052005
|
MeSH Number(s) |
D08.811.913.696.620.682.700.109.500 D12.776.543.750.750.400.049.500
|
Concept/Terms |
Bone Morphogenetic Protein Receptors, Type I- Bone Morphogenetic Protein Receptors, Type I
- BMPR-I Receptors
- BMPR I Receptors
- Type I Bone Morphogenetic Protein Receptors
- BMP Type I Receptor
- Bone Morphogenetic Protein Receptor Type I
Bone Morphogenetic Protein Receptor, Type IA- Bone Morphogenetic Protein Receptor, Type IA
- Type IA Bone Morphogenetic Protein Receptor
- BMPR-IA Receptor
- BMPR IA Receptor
- Activin Receptor-Like Kinase 3
- Activin Receptor Like Kinase 3
- BMP Type IA Receptor
Bone Morphogenetic Protein Receptor, Type IB- Bone Morphogenetic Protein Receptor, Type IB
- Type IB Bone Morphogenetic Protein Receptor
- BMPR-IB Receptor
- BMPR IB Receptor
- Serine-Threonine Protein Kinase Receptor R6
- Serine Threonine Protein Kinase Receptor R6
- Activin Receptor-Like Kinase 6
- Activin Receptor Like Kinase 6
- BMP Type IB Receptor
|
Below are MeSH descriptors whose meaning is more general than "Bone Morphogenetic Protein Receptors, Type I".
Below are MeSH descriptors whose meaning is more specific than "Bone Morphogenetic Protein Receptors, Type I".
This graph shows the total number of publications written about "Bone Morphogenetic Protein Receptors, Type I" by people in this website by year, and whether "Bone Morphogenetic Protein Receptors, Type I" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2012 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Morphogenetic Protein Receptors, Type I" by people in Profiles.
-
Canali S, Core AB, Zumbrennen-Bullough KB, Merkulova M, Wang CY, Schneyer AL, Pietrangelo A, Babitt JL. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice. Endocrinology. 2016 Mar; 157(3):1146-62.
-
Wu X, Zhang N, Lee MM. Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation. Endocrinology. 2012 Oct; 153(10):4929-37.
-
Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W, Okada H, Carlson W, Bey P, Rusckowski M, Tampe B, Tampe D, Kanasaki K, Zeisberg M, Kalluri R. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med. 2012 Feb 05; 18(3):396-404.
-
Bramono DS, Murali S, Rai B, Ling L, Poh WT, Lim ZX, Stein GS, Nurcombe V, van Wijnen AJ, Cool SM. Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone. 2012 Apr; 50(4):954-64.
-
Hoshiya Y, Gupta V, Segev DL, Hoshiya M, Carey JL, Sasur LM, Tran TT, Ha TU, Maheswaran S. Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells. Mol Cell Endocrinol. 2003 Dec 15; 211(1-2):43-9.
-
Kobielak K, Pasolli HA, Alonso L, Polak L, Fuchs E. Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. J Cell Biol. 2003 Nov 10; 163(3):609-23.